Hellenia Feverfew Extract 25 mg - 180 Tablets - Traditional Migraine Relief from Lifesource Supplements Ltd
£11.05
As of 2020-04-08 23:15:05 UTC (more info)
Product prices and availability are accurate as of 2020-04-08 23:15:05 UTC and are subject to change. Any price and availability information displayed on https://www.amazon.co.uk/ at the time of purchase will apply to the purchase of this product.
Availability:
Not Available - stock arriving soon
Product Description
We are happy to offer the superb Hellenia Feverfew Extract 25 mg - 180 Tablets - Traditional Migraine Relief.
With so many on offer recently, it is wise to have a make you can recognise. The Hellenia Feverfew Extract 25 mg - 180 Tablets - Traditional Migraine Relief is certainly that and will be a perfect acquisition.
For this price, the Hellenia Feverfew Extract 25 mg - 180 Tablets - Traditional Migraine Relief is highly respected and is a regular choice with many people. Lifesource Supplements Ltd have provided some nice touches and this equals good value for money.
Manufacturer Description
Feverfew is used as a traditonal preventative (or prophylactic) treatment for migraine. Feverfew (Tanacetum parthenium) is a perennial plant belonging to the daisy family which grows in much of Europe, North America and Canada. It has been used in herbal remedies for centuries. Unlike many other health food supplement manufacturers, Hellenia is a family company and has been formulating and supplying quality health food supplements in the UK for nearly thirty years. All products manufactured in Great Britain to ISO 9001 Standard. For maximum benefit take 1 tablet a day as and when required.
Product Features
Feverfew Extract 25 mg - 180 Tablets
Traditionally used to relieve migraines
All products manufactured in Great Britain to ISO 9001 Standard
Unlike many other health food supplement manufacturers, Hellenia is a family company and has been formulating and supplying quality health food supplements in the UK for nearly thirty years.
Packaging may vary but contents will remain the same.
